MyFinsight
Home
Blog
About
Contact
Download
Download image
something is missing
$2,585,856K
Borrowings under revolving
and securitization...
$47,212,956K
(67.56%↑ Y/Y)
Inventories
-$3,399,637K
(-101.23%↓ Y/Y)
Senior notes and loan
borrowings
$4,540,483K
(199.77%↑ Y/Y)
Net income
$1,629,528K
(127.14%↑ Y/Y)
Accounts receivable
-$522,077K
(30.96%↑ Y/Y)
Provision for deferred
income taxes
$178,407K
(580.68%↑ Y/Y)
Depreciation, including
amounts charged to cost...
$142,302K
(15.13%↑ Y/Y)
Amortization, including
amounts charged to...
$120,675K
(-14.03%↓ Y/Y)
Adjustments to rca and
oneoncology equity units
$92,905K
(148.01%↑ Y/Y)
Accrued expenses
$70,971K
(146.90%↑ Y/Y)
Prepaid expenses and
other assets
-$68,490K
(-185.82%↓ Y/Y)
Share-based compensation
expense
$28,002K
(-1.58%↓ Y/Y)
Decrease in cash, cash
equivalents, and restricted...
$427,569K
(135.15%↑ Y/Y)
Canceled cashflow
$2,158,287K
Net cash provided by
financing activities
$3,978,567K
(909.08%↑ Y/Y)
Net cash (used in)
provided by operating...
$1,338,639K
(-60.06%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
$9,751K
(468.57%↑ Y/Y)
Canceled cashflow
$47,767,274K
Canceled cashflow
$4,887,369K
Decrease in cash, cash
equivalents, and restricted...
-$2,133,800K
Less increase in cash
classified within assets...
-$24,487K
Canceled cashflow
$5,326,957K
Non-customer note receivable
$20,626K
Proceeds from sale of
assets
$717K
Repayments under revolving
and securitization...
$47,424,106K
(60.64%↑ Y/Y)
Senior notes and loan
repayments
$217,784K
(-82.50%↓ Y/Y)
Cash dividends on
common stock
$117,456K
(5.64%↑ Y/Y)
Employee tax
withholdings related to...
$7,035K
(95.69%↑ Y/Y)
Other, net
-$893K
(52.65%↑ Y/Y)
Accounts payable
-$3,501,753K
(-22766.35%↓ Y/Y)
Remeasurement gain related to
oneoncology acquisition...
$1,086,612K
Lifo (credit)
expense
-$210,030K
(-632.14%↓ Y/Y)
Income taxes payable
and other...
-$78,174K
(17.28%↑ Y/Y)
Other, net
$5,681K
(305.31%↑ Y/Y)
(benefit) provision for
credit losses
-$4,885K
(-157.58%↓ Y/Y)
Gain on sale of assets
$234K
Net cash used in
investing activities
-$4,874,901K
(-19.55%↓ Y/Y)
Canceled cashflow
$21,343K
something is missing
-$2,585,856K
Cost of acquired
companies, net of cash...
$4,712,350K
(19.64%↑ Y/Y)
Capital expenditures
$165,618K
(28.33%↑ Y/Y)
Other, net
$9,776K
(1412.21%↑ Y/Y)
Cost of equity
investments
$8,500K
(-19.52%↓ Y/Y)
Back
Back
Cash Flow
cencora-logo-svg
Cencora, Inc. (COR)
cencora-logo-svg
Cencora, Inc. (COR)
source: myfinsight.com